Breast cancer risk after exposure to perfluorinated compounds in Danish women: a case–control study nested in the Danish National Birth Cohort

Cancer Causes and Control

Volumn 25, Issue 11, 2014, Pages 1439-1448

  Bonefeld Jørgensen, Eva C ^a   Long, Manhai ^a   Fredslund, Stine Overvad ^a   Bossi, Rossana ^a   Olsen, Jørn ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Breast cancer; Perfluoroalkyl substances; Premenopausal Danish women; Prospective collected data

Indexed keywords

PERFLUORO COMPOUND; PERFLUORO N PENTANOIC ACID; PERFLUOROALKYL SUBSTANCE; PERFLUOROBUTANE SULFONATE; PERFLUORODECANE SULFONATE; PERFLUORODECANOIC ACID; PERFLUORODODECANOIC ACID; PERFLUOROHEPTANE SULFONATE; PERFLUOROHEPTANOIC ACID; PERFLUOROHEXANE SULFONATE; PERFLUOROHEXANOIC ACID; PERFLUORONONANOIC ACID; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; PERFLUOROTETRADECANOIC ACID; PERFLUOROTRIDECANOIC ACID; PERFLUOROUNDECANOIC ACID; PERFLUROOCTANE SULFONAMIDE; UNCLASSIFIED DRUG; ALKANESULFONIC ACID; PERFLUOROHEXANESULFONIC ACID; POLLUTANT; SULFONIC ACID DERIVATIVE;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; BODY MASS; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DANISH CITIZEN; DISEASE ASSOCIATION; ELECTROSPRAY MASS SPECTROMETRY; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MATERNAL SMOKING; PREGNANCY; PREMENOPAUSE; QUESTIONNAIRE; RISK FACTOR; TANDEM MASS SPECTROMETRY; ADVERSE EFFECTS; BLOOD; BREAST NEOPLASMS; CHEMICALLY INDUCED; COHORT ANALYSIS; DENMARK; INTERVIEW; MIDDLE AGED; POLLUTANT; YOUNG ADULT;

ADULT; ALKANESULFONIC ACIDS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; DENMARK; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MIDDLE AGED; PREGNANCY; RISK FACTORS; SULFONIC ACIDS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84911491564     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-014-0446-7     Document Type: Article

References (62)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
2. Kræftens bekæmpelse sob (2011) http://www.cancer.dk/Hjaelp+viden/kraeftformer/kraeftsygdomme/brystkraeft/statistik+brystkraeft/
3. Cancerregisteret (2011) http://www.ssi.dk/Sundhedsdataogit/Registre/~/media/Indhold/DK%20-%20dansk/Sundhedsdata%20og%20it/NSF/Registre/Cancerregisteret/Cancerregisteret%202011.ashx
4. Campeau P, Foulkes W, Tischkowitz M (2008) Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet 124:31–42
5. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JWW (2008) Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44:1345–1389
6. Fredslund SO, Bonefeld-Jorgensen EC (2012) Breast cancer in the Arctic—changes over the past decades. Int J Circumpolar Health 71:19155
7. Bonefeld-Jorgensen EC, Long M, Bossi R, Ayotte P, Asmund G, Kruger T, Ghisari M, Mulvad G, Kern P, Nzulumiki P, Dewailly E (2011) Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study. Environ Health 10:88
8. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN (1995) Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87:1681–1685
9. Sargent JW, Seffl RJ (1970) Properties of perfluorinated liquids. Fed Proc 29:1699–1703
10. Dimitrov S, Kamenska V, Walker JD, Windle W, Purdy R, Lewis M, Mekenyan O (2004) Predicting the biodegradation products of perfluorinated chemicals using CATABOL. SAR QSAR Environ Res 15:69–82
11. Giesy JP, Kannan K, Jones PD (2001) Global biomonitoring of perfluorinated organics. Sci World J 1:627–629
12. Giesy JP, Kannan K (2001) Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 35:1339–1342
13. OECD (2002) Hazard assessment of perfluorooctane sulfonate and its salts.ENV/JM/EXCH, 8, Paris, France
14. Stockholmconvention (2009–2014) Fourth meeting of the conference of the parties of the Stockholm convention. Stockholm convention on persistent organic pollutants. Geneve, Switzerland
15. Kennedy GL Jr, Butenhoff JL, Olsen GW, O’Connor JC, Seacat AM, Perkins RG, Biegel LB, Murphy SR, Farrar DG (2004) The toxicology of perfluorooctanoate. Crit Rev Toxicol 34:351–384
16. Butenhoff JL, Gaylor DW, Moore JA, Olsen GW, Rodricks J, Mandel JH, Zobel LR (2004) Characterization of risk for general population exposure to perfluorooctanoate. Regul Toxicol Pharmacol 39:363–380
17. Andersen ME, Butenhoff JL, Chang SC, Farrar DG, Kennedy GL Jr, Lau C, Olsen GW, Seed J, Wallace KB (2008) Perfluoroalkyl acids and related chemistries–toxicokinetics and modes of action. Toxicol Sci 102:3–14
18. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J (2007) Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366–394
19. Fuentes S, Vicens P, Colomina MT, Domingo JL (2007) Behavioral effects in adult mice exposed to perfluorooctane sulfonate (PFOS). Toxicology 242:123–129
20. Johansson N, Eriksson P, Viberg H (2009) Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain. Toxicol Sci 108:412–418
21. U.S. EPA (2006) Draft risk assessment of potential human health effects associated with PFOA and its salts. U.S. EPA SAB, May 30, 2006, U.S.EPA public docket EPA-SAB-06-006, Washington, DC
22. Sibinski LJ (1987) Final report of a two year oral (diet) toxicity and carcinogenicity study of fluorochemical FC-143 (perfluorooctanane ammonium carboxylate) in rats. 3M Company/RIKER Exp. No. 0281CR0012; 8EHQ-1087-0394, pp 1–4
23. Hardisty JF, Willson GA, Brown WR, McConnell EE, Frame SR, Gaylor DW, Kennedy GL, Butenhoff JL (2010) Pathology Working Group review and evaluation of proliferative lesions of mammary gland tissues in female rats fed ammonium perfluorooctanoate (APFO) in the diet for 2 years. Drug Chem Toxicol 33:131–137
24. Butenhoff JL, Kennedy GL Jr, Chang SC, Olsen GW (2012) Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague–Dawley rats. Toxicology 298:1–13
25. White SS, Calafat AM, Kuklenyik Z, Villanueva L, Zehr RD, Helfant L, Strynar MJ, Lindstrom AB, Thibodeaux JR, Wood C, Fenton SE (2007) Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci 96:133–144
26. Kropp T, Houlihan J (2005) Evaluating human health risks from exposure to perfluorooctanoic acid (PFOA): recommendations to the Science Advisory Board’s PFOA Review Panel. In: Presented February 10, 2005 to the US EPA Science Advisory Board’s PFOA Review Panel, in Washington, DC
27. Ghisari M, Eiberg H, Long M, Bonefeld-Jørgensen EC (2014) Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case–control study in Inuit women. Environ Health 13(1):19
28. Olsen J, Melbye M, Olsen SF, Sorensen TI, Aaby P, Andersen AM, Taxbol D, Hansen KD, Juhl M, Schow TB, Sorensen HT, Andresen J, Mortensen EL, Olesen AW, Sondergaard C (2001) The Danish National Birth Cohort—its background, structure and aim. Scand J Public Health 29:300–307
29. Danish National Birth Cohort (2011) http://www.ssi.dk/English/RandD/Research%20areas/Epidemiology/DNBC/
30. Sundhedsstyrelsen [Internet], Landspatientregisteret, [cited 2011] Available from: http://www.sst.dk/Indberetning%20og%20statistik/Landspatientregisteret.aspx
31. Keller JM, Calafat AM, Kato K, Ellefson ME, Reagen WK, Strynar M, O’Connell S, Butt CM, Mabury SA, Small J, Muir DC, Leigh SD, Schantz MM (2010) Determination of perfluorinated alkyl acid concentrations in human serum and milk standard reference materials. Anal Bioanal Chem 397:439–451
32. AMAP (2010) AMAP Ring Test for Persistent Organic Pollutants in Human Serum
33. Greenland S (1989) Modeling and variable selection in epidemiologic analysis. Am J Public Health 79:340–349
34. Olsen GW, Church TR, Larson EB, van Belle G, Lundberg JK, Hansen KJ, Burris JM, Mandel JH, Zobel LR (2004) Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle Washington. Chemosphere 54:1599–1611
35. Lehmler HJ (2005) Synthesis of environmentally relevant fluorinated surfactants—a review. Chemosphere 58:1471–1496
36. Olsen GW, Church TR, Miller JP, Burris JM, Hansen KJ, Lundberg JK, Armitage JB, Herron RM, Medhdizadehkashi Z, Nobiletti JB, O’Neill EM, Mandel JH, Zobel LR (2003) Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ Health Perspect 111:1892–1901
37. Starkov AA, Wallace KB (2002) Structural determinants of fluorochemical-induced mitochondrial dysfunction. Toxicol Sci 66:244–252
38. Houde M, Martin JW, Letcher RJ, Solomon KR, Muir DC (2006) Biological monitoring of polyfluoroalkyl substances: a review. Environ Sci Technol 40:3463–3473
39. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Tully JS, Needham LL (2007) Serum concentrations of 11 polyfluoroalkyl compounds in the US population: data from the National Health and Nutrition Examination Survey (NHANES). Environ Sci Technol 41:2237–2242
40. Calafat AM, Needham LL, Kuklenyik Z, Reidy JA, Tully JS, Aguilar-Villalobos M, Naeher LP (2006) Perfluorinated chemicals in selected residents of the American continent. Chemosphere 63:490–496
41. Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL (2007) Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and comparisons with NHANES 1999–2000. Environ Health Perspect 115:1596–1602
42. Karrman A, van Bavel B, Jarnberg U, Hardell L, Lindstrom G (2006) Perfluorinated chemicals in relation to other persistent organic pollutants in human blood. Chemosphere 64:1582–1591
43. Karrman A, Langlois I, van Bavel B, Lindstrom G, Oehme M (2007) Identification and pattern of perfluorooctane sulfonate (PFOS) isomers in human serum and plasma. Environ Int 33:782–788
44. Karrman A, Ericson I, van Bavel B, Darnerud PO, Aune M, Glynn A, Lignell S, Lindstrom G (2007) Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996–2004, in Sweden. Environ Health Perspect 115:226–230
45. Karrman A, Bavel Bv, Hardell L, Lindström G, Järnberg U (2004) Perfluoroalkylated compounds in whole blood and plasma from the Swedish population. Department of Natural Sciences MTM Research Centre
46. Slotkin TA, MacKillop EA, Melnick RL, Thayer KA, Seidler FJ (2008) Developmental neurotoxicity of perfluorinated chemicals modeled in vitro. Environ Health Perspect 116:716–722
47. Beesoon S, Genuis SJ, Benskin JP, Martin JW (2012) Exceptionally high serum concentrations of perfluorohexanesulfonate in a Canadian family are linked to home carpet treatment applications. Environ Sci Technol 46:12960–12967
48. Viberg H, Lee I, Eriksson P (2013) Adult dose-dependent behavioral and cognitive disturbances after a single neonatal PFHxS dose. Toxicology 304:185–191
49. Johansson N, Fredriksson A, Eriksson P (2008) Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. Neurotoxicology 29:160–169
50. Gump BB, Wu Q, Dumas AK, Kannan K (2011) Perfluorochemical (PFC) exposure in children: associations with impaired response inhibition. Environ Sci Technol 45:8151–8159
51. Stein CR, Savitz DA (2011) Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5–18 years of age. Environ Health Perspect 119:1466–1471
52. Lim TC, Wang B, Huang J, Deng S, Yu G (2011) Emission inventory for PFOS in China: review of past methodologies and suggestions. Sci World J 11:1963–1980
53. Kjeldsen LS, Bonefeld-Jorgensen EC (2013) Perfluorinated compounds affect the function of sex hormone receptors. Environ Sci Pollut Res 20:8031–8044
54. Long M, Ghisari M, Bonefeld-Jorgensen EC (2013) Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor. Environ Sci Pollut Res 20:8045–8056
55. Rosenmai AK, Nielsen FK, Pedersen M, Hadrup N, Trier X, Christensen JH, Vinggaard AM (2013) Fluorochemicals used in food packaging inhibit male sex hormone synthesis. Toxicol Appl Pharmacol 266:132–142
56. Maras M, Vanparys C, Muylle F, Robbens J, Berger U, Barber JL, Blust R, De Coen W (2006) Estrogen-like properties of fluorotelomer alcohols as revealed by MCF-7 breast cancer cell proliferation. Environ Health Perspect 114:100–105
57. Eriksen KT, Raaschou-Nielsen O, Sorensen M, Roursgaard M, Loft S, Moller P (2010) Genotoxic potential of the perfluorinated chemicals PFOA, PFOS, PFBS, PFNA and PFHxA in human HepG2 cells. Mutat Res 700:39–43
58. Florentin A, Deblonde T, Diguio N, Hautemaniere A, Hartemann P (2011) Impacts of two perfluorinated compounds (PFOS and PFOA) on human hepatoma cells: cytotoxicity but no genotoxicity? Int J Hyg Environ Health 214:493–499
59. Yao X, Zhong L (2005) Genotoxic risk and oxidative DNA damage in HepG2 cells exposed to perfluorooctanoic acid. Mutat Res Genet Toxicol Environ Mutagen 587:38–44
60. Huang Q, Zhang J, Martin FL, Peng S, Tian M, Mu X, Shen H (2013) Perfluorooctanoic acid induces apoptosis through the p53-dependent mitochondrial pathway in human hepatic cells: a proteomic study. Toxicol Lett 223:211–220
61. Grandjean P, Andersen EW, Budtz-Jorgensen E, Nielsen F, Molbak K, Weihe P, Heilmann C (2012) Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 307:391–397
62. Grandjean P, Budtz-Jorgensen E (2013) Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children. Environ Health 12:35